We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current EOLS market cap is 558.93M. The company's latest EPS is USD -1.3020 and P/E is -7.50.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 37.16M | 33.9M | 43.65M | 41.72M | 49.35M |
| Operating Income | -18.62M | -16.68M | -14.58M | -10.39M | -13.44M |
| Net Income | -23.47M | -20.28M | -13.16M | -14.79M | -18.14M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 34.93M | 58.55M | 99.67M | 148.62M |
| Operating Income | -46.14M | -98.95M | -153.07M | -69.91M | -65.33M |
| Net Income | -46.87M | -90.03M | -163.01M | -46.81M | -74.41M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 210.92M | 192.72M | 177.98M | 160.24M | 168.98M |
| Total Liabilities | 164.06M | 163.5M | 159.48M | 153.29M | 175.95M |
| Total Equity | 46.86M | 29.22M | 18.5M | 6.95M | -6.96M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 171.84M | 240.44M | 209.07M | 257.48M | 177.98M |
| Total Liabilities | 87.46M | 160.99M | 282.03M | 175.61M | 159.48M |
| Total Equity | 84.38M | 79.46M | -72.96M | 81.88M | 18.5M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -59.09M | -76.14M | -84.91M | -20.59M | -33.9M |
| Investing | -649k | -1.55M | -2.94M | -511k | -727k |
| Financing | -1.87M | -2.63M | -4.15M | -1.28M | 22.54M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -25.67M | -93.38M | -57.87M | -33.39M | -84.91M |
| Investing | -9k | -23.43M | 12.19M | 4.03M | -2.94M |
| Financing | 118.86M | 133.55M | 38.35M | 73.05M | -4.15M |
| Market Cap | 558.93M |
| Price to Earnings Ratio | -7.50 |
| Price to Sales Ratio | 3.76 |
| Price to Cash Ratio | 10.36 |
| Price to Book Ratio | 30.18 |
| Dividend Yield | - |
| Shares Outstanding | 57.15M |
| Average Volume (1 week) | 410.93k |
| Average Volume (1 Month) | 809.45k |
| 52 Week Change | 37.17% |
| 52 Week High | 11.49 |
| 52 Week Low | 6.51 |
| Spread (Intraday) | 0.62 (6.16%) |
| Company Name | Evolus Inc |
| Address |
838 walker road dover, delaware 19904 |
| Website | https://www.evolus.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
